Navigation Links
Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors

COMMACK, N.Y., Oct. 15 /PRNewswire/ -- It is with great privilege that Avery Biomedical Devices, Inc. (ABD) announces the appointment of John A. Elefteriades, M.D., F.A.C.S. to its Board of Directors.

Dr. Elefteriades is the William W.L. Glenn Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery at Yale University and Yale-New Haven Hospital. He serves as Co-Director of the Yale-New Haven Hospital Heart Center. He is recognized consistently in America's Top Doctors published by Castle Connolly. He serves on the Editorial Boards of the American Journal of Cardiology, Cardiology, The International Journal of Angiology, The Journal of Cardiac Surgery, and The Journal of Thoracic and Cardiovascular Surgery, among others. He has served on the Board of Governors of the American College of Cardiology and as President of the International College of Angiology. He has recently served on a steering committee for future research at the National Science Foundation.

Dr. Elefteriades has conducted award-winning pioneering research in cardiac surgery and has been instrumental in the development and testing of many medical devices, including ABD's phrenic nerve stimulator. He has published over 200 scientific papers and dozens of book chapters, as well as several textbooks of medicine and surgery. For the lay public, he has authored the recently published Your Heart: An Owner's Guide and the upcoming The Women's Heart: An Owner's Guide.

Linda Towler, CEO, states, "We are honored to have Dr. Elefteriades join our Board of Directors. His experience and expertise will be invaluable to the future growth of ABD."

Dr. Elefteriades states, "It is a privilege to serve on the Board of Directors of ABD. This company has served the world's need in diaphragm pacing. Exciting new products are under development in this and related arenas as well. I look forward to providing medical and surgical input to the Board."


Avery Biomedical Devices, Inc. (ABD) is a privately-held biomedical device manufacturer located on Long Island, New York. It produces the breathing pacemaker: an implanted phrenic nerve stimulator which is used to free many quadriplegic and central hypoventilation patients from mechanical ventilation. Through its wholly-owned subsidiary, ABD Custom Manufacturing, Inc., ABD manufactures high-quality platinum contact electrodes for research projects, clinical trials and commercially distributed medical devices.

ABD is ISO-9001 certified, ISO-13485 compliant, and an FDA registered manufacturer of Class III medical devices.

Should you know a patient with quadriplegia, central sleep apnea or other condition that may benefit from a breathing pacemaker, or if you are interested in our ABD Custom products, please contact us.


Kenneth R. Aron, V. P. Sales & Marketing


SOURCE Avery Biomedical Devices, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. UW Academic ADL Co-Lab joins worldwide effort against slavery
2. Biomedical engineering conference invites manufacturers
3. Manufacturing partnership will move into biotech and biomedical spaces
4. Biomedical Alliance about more than stem cells
5. Doyle seeks $2.5M for biomedical alliance
6. Students will show off biomedical devices to professors and investors
7. Biomedical alliance marks first full year
8. UW Biomedical Engineering awarded $2.9 million research grant
9. Having two biomedical tech centers in Wisconsin will help the state
10. New biomedical institute aims to unite business and academia in SE Wisconsin
11. Wisconsin publicly traded biomedical companies report gains this quarter
Post Your Comments:
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
(Date:11/24/2015)... VANCOUVER , Nov. 24, 2015 /CNW/ - iCo ... ICOTF), today reported financial results for the quarter ... are expressed in Canadian dollars and presented under ... the United States ," said Andrew ... "These advancements regarding iCo-008 are not only value ...
(Date:11/24/2015)... Global, Inc., a worldwide provider of clinical research services headquartered in ... company has set a new quarterly earnings record in Q3 of ... for Q3 of 2014 to Q3 of 2015.   ... with the establishment of an Asia-Pacific office ... Kingdom and Mexico , with the ...
(Date:11/24/2015)... LEXINGTON, Massachusetts , November 24, 2015 ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ... Poulton , Chief Financial Officer, will participate in the Piper Jaffray ... City , NY on Tuesday, December 1, 2015, at 8:30 ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):